Hysteroscopic Septoplasty: Uterine Septum Removal

Hysteroscopic septoplasty is a minimally invasive procedure that removes the wall of tissue (the septum) dividing the inside of a uterus into two compartments. It has been standard treatment for the septate uterus for decades, yet a surprising amount of debate still surrounds whether, and for whom, it genuinely improves reproductive outcomes. The surgery itself is quick, low-risk, and well-established, but the evidence supporting it is more complicated than many patients are told.

What a Septate Uterus Is and Why It Matters

A septate uterus forms during fetal development when the two tubes that normally fuse to create a single uterine cavity fail to fully resorb the tissue between them. The result is a fibrous or fibromuscular wall hanging down from the top of the uterus, partially or completely dividing the cavity. From the outside, the uterus looks normal; the problem is entirely internal. This makes it different from a bicornuate uterus, which has a visible indentation or heart shape on the outer surface and involves a structural split of the uterine muscle itself.

Getting this distinction right matters because the treatment differs dramatically. A septate uterus can be treated hysteroscopically, while a bicornuate uterus cannot. MRI has traditionally been considered the gold standard for telling the two apart, because it provides clear images of the outer uterine contour, which is the key to the diagnosis.

Three-dimensional ultrasound has increasingly become a viable alternative. One study comparing 3D ultrasound to MRI found that for identifying septate uteri, 3D ultrasound had 100% sensitivity and about 89% specificity, with very high agreement between the two imaging methods.

Getting the Diagnosis Right

One of the trickiest aspects of managing a septate uterus is that different classification systems define it differently. The two main systems used worldwide set different thresholds for how deep the internal indentation needs to be and how much of the uterine wall the septum must occupy before the diagnosis applies. Under one system, a septum is diagnosed when the internal indentation is deeper than 1.5 centimeters and the outer fundal indentation is less than 1 centimeter. Under the other, the internal indentation must exceed 50% of the uterine wall thickness while the external cleft stays below 50%.¹

This discrepancy is not just academic. A woman classified as having a septate uterus under one system might not qualify under the other, which means she might be offered surgery in one clinic and watchful waiting in another. When reading about septoplasty outcomes, it helps to know which classification system was used, because the patient populations across studies are not always comparable.

MRI remains especially useful in complex cases involving extensive septal tissue or unusual anatomy, where the detail it provides about the external fundal contour can be decisive.² For straightforward cases, 3D ultrasound in experienced hands performs nearly as well and is less expensive and more accessible.³

The Procedure Itself

The surgery is performed through the cervix using a hysteroscope, a thin telescope that enters the uterine cavity without any abdominal incisions. The surgeon identifies the septum and divides it, typically starting at its lower edge and working upward toward the fundus (the top of the uterus). The goal is to create a single, unified cavity while avoiding cutting too deep into the muscular wall. The whole procedure usually takes between 10 and 30 minutes, depending on the size of the septum and the technique used. Most patients go home the same day.

The septum can be divided using several different tools, and the choice matters more than you might expect. Cold scissors, electrosurgical instruments (resectoscopes), and lasers all get the job done, but their downstream effects differ. A network meta-analysis comparing these approaches found that mechanical cutting with scissors was associated with higher clinical pregnancy rates than electrosurgical resection, while miscarriage and live birth rates were comparable across techniques.⁴

The advantage of scissors appears to relate to tissue damage. A separate meta-analysis focused on hysteroscopic procedures more broadly found that cold scissors led to shorter operating times, less blood loss, and a markedly lower rate of adhesion recurrence compared to electrosurgery.⁵ Electrosurgery generates heat that can damage surrounding endometrium, potentially leaving behind scarred tissue that acts as a seed for adhesion formation. Scissors cut cleanly without thermal spread.

Laser-based techniques represent a newer option. A pilot study using a diode laser for office hysteroscopic septoplasty reported no complications, average operating times around 13 minutes, and mild pain scores, with complete septum removal confirmed at follow-up and no adhesion formation.⁶ The appeal is that vaporization may minimize the raw surface area left behind, though larger comparative studies are still needed.

Safety and Complications

Hysteroscopic septoplasty is generally a low-risk procedure. In a single-center retrospective study of over 150 electrosurgical septum resections, no uterine perforations, fluid-overload events, or major hemorrhages occurred. The only recorded complication was one case of postoperative endometritis, a rate of about 0.6%.⁷

When electrosurgery is used, the choice between monopolar and bipolar instruments matters for fluid management. Monopolar resectoscopes require non-conductive distension fluid (like glycine), which can cause dangerously low sodium levels if too much is absorbed. A comparative study found that fluid overload and postoperative drops in sodium were both significantly worse with monopolar instruments.⁸ Bipolar systems use normal saline, which the body handles much more forgivingly. Most modern centers have shifted to bipolar technology for this reason, or bypass the question altogether by using scissors.

Preventing Adhesions After Surgery

The main postoperative concern is intrauterine adhesion formation. When the septum is cut away, it leaves raw surfaces on both walls of the cavity that can stick together as they heal, potentially re-creating a barrier or causing scarring that compromises fertility. How best to prevent this has been debated for years.

Hyaluronic acid gel applied to the uterine cavity after surgery appears to help substantially. In one study, adhesion rates were about 9% in the group that received hyaluronic acid gel compared to about 43% in the control group, an absolute risk reduction of roughly 34 percentage points and a relative risk reduction of about 80%. The adhesions that did form in the gel group were thin and involved less than a third of the cavity.⁹

Two other strategies that were widely used for years have not held up as well. A prospective randomized study found that estrogen treatment after septum resection did not significantly prevent adhesions or improve reproductive outcomes compared to no estrogen.¹⁰ Similarly, neither intrauterine device placement, estrogen therapy, nor the combination of both was found to prevent adhesions or help with pregnancy after septum resection in another study.¹¹ Despite this evidence, some clinics still prescribe postoperative estrogen as a matter of habit.

Follow-Up After the Procedure

Historically, a second-look hysteroscopy has been performed a few weeks to a couple of months after septoplasty to confirm the septum was fully removed and to check for adhesions. This is an additional procedure that, while minor, still involves entering the uterus. A systematic review found that selective use of 3D sonohysterography (an ultrasound performed while fluid distends the uterine cavity) showed high agreement with hysteroscopy for postoperative assessment, potentially reducing the need for routine invasive follow-up.¹² For many patients, this imaging-based approach can replace the second surgery.

Reproductive Outcomes and the Big Controversy

Here is where the story gets complicated. For decades, observational data has consistently shown dramatic improvements in pregnancy outcomes after septoplasty, particularly for women with recurrent miscarriage. One study of women who had experienced repeated pregnancy loss found that the miscarriage rate dropped from about 95% before surgery to 24% afterward.¹³ Retrospective and systematic reviews have similarly reported that hysteroscopic septoplasty significantly improves reproductive performance, especially in women with recurrent loss.¹⁴

For women with unexplained infertility and a septate uterus, the numbers are also encouraging. A pooled analysis found an overall pregnancy rate of about 60% and a live birth rate of about 45% after septoplasty.¹⁵ A controlled trial comparing women who had septoplasty to women with unexplained infertility and a normal uterus found significantly higher pregnancy rates (about 39% vs. 20%) and live birth rates (about 34% vs. 19%) in the septoplasty group.¹⁶ A systematic review and meta-analysis confirmed that women with primary unexplained infertility and a uterine septum had significantly higher live birth and pregnancy rates after resection.¹⁷

But then came the randomized controlled trial that disrupted the consensus. The TRUST trial, published in 2021, randomly assigned women with a septate uterus to either septum resection or expectant management. Live birth occurred in 31% of women in the surgery group and 35% in the watch-and-wait group, with no meaningful difference between them. There was also no difference in clinical pregnancy, ongoing pregnancy, miscarriage, or preterm birth rates.¹⁸ A Cochrane review incorporating this trial concluded that there may be little to no difference in live birth between septum resection and expectant management.¹⁹

How can the observational studies be so positive while the randomized trial shows no benefit? Several factors likely contribute. Most observational studies compare outcomes in the same women before and after surgery, which is vulnerable to a statistical effect called regression to the mean: women who were referred because of repeated miscarriages are likely to have better outcomes on their next pregnancy regardless of any intervention. The TRUST trial, by including women regardless of their loss history, may also have diluted the effect in the population that benefits most. The trial was small (79 women) and acknowledged that it was underpowered to detect clinically relevant differences in subgroups. And the classification thresholds used to define a septate uterus in the trial may have included some women with very small septa who had little to gain from surgery.

This leaves clinicians and patients in an awkward position. The highest-quality evidence type (randomized trial) suggests no benefit, while the bulk of clinical experience and a much larger body of observational data suggests the procedure helps, at least in certain populations. Many experts argue that septoplasty remains appropriate for women with recurrent miscarriage and a clear septum, where the before-and-after improvements are too large and too consistent to be explained entirely by regression to the mean. For women found incidentally to have a small septum and no reproductive difficulties, the TRUST trial suggests watchful waiting is reasonable.

Obstetric Outcomes After Septoplasty

For women who become pregnant after septoplasty, the obstetric picture is generally reassuring but includes some noteworthy patterns. In one study of nulliparous women, septum resection was associated with delivery about two weeks later on average (39 weeks vs. 37 weeks) and a substantially lower preterm birth rate compared to women with an unresected septum. However, the same study found a higher cesarean delivery rate in women who had undergone septum resection, including among those who attempted vaginal delivery.²⁰ The reason for the increased cesarean rate is not entirely clear; it may relate to provider concern about the resection site or to labor dystocia in a cavity whose shape has been surgically altered.

A separate retrospective cohort reported a preterm labor rate of about 7% and preeclampsia in about 5% of pregnancies after septoplasty, with vaginal delivery being the most common mode at about 82%.²¹ These figures are broadly comparable to the general obstetric population, suggesting that a prior septoplasty does not place most pregnancies in a high-risk category by default.

Uterine Rupture After Septoplasty

One rare but serious concern is uterine rupture during a subsequent pregnancy. A case series described four women who experienced rupture after hysteroscopic surgery, three of whom had undergone septum resection. Rupture occurred between 10 and 38 weeks of pregnancy, with the earliest case representing one of the earliest documented ruptures in the medical literature. All four patients had conceived less than a year after surgery, and the authors suggested that a short interval between the procedure and pregnancy may increase the risk.²²

This is a genuinely rare complication, and the case-series format means it is impossible to estimate a true incidence rate. Still, it has led many surgeons to advise waiting at least two to three months after septoplasty before attempting conception, to allow the uterine wall to heal fully. Some recommend longer intervals if significant myometrial tissue was involved in the resection.

Office-Based Septoplasty

A growing trend is performing septoplasty in an outpatient or office setting, without general anesthesia. Smaller hysteroscopes, improved optics, and energy sources like the diode laser have made this feasible for appropriately selected patients with smaller septa. In the pilot study mentioned earlier, office procedures with a diode laser were completed in about 13 minutes with mild pain scores and no complications.²³ For larger or more complex septa, operating-room hysteroscopy with sedation or general anesthesia remains the standard approach. The decision depends on septum size, patient tolerance, and the equipment available.

What About Cost?

One area that remains conspicuously under-studied is cost-effectiveness. A formal analysis noted that no cost-effectiveness studies have been published, and the cost of septoplasty varies widely depending on the healthcare system, the setting (office vs. operating room), the energy source used, and whether additional procedures like a second-look hysteroscopy are included.²⁴ In systems where the procedure requires a hospital admission and general anesthesia, costs climb substantially. Office-based approaches could change this equation, but the economic data simply does not exist yet to guide formal recommendations.

Who Should Consider the Procedure

Given the tension in the evidence, the most pragmatic way to think about septoplasty is through the lens of individual clinical context. Women with recurrent miscarriage and a clearly defined septum have the strongest case for surgery, based on consistent (if non-randomized) evidence of dramatic reductions in subsequent loss rates. Women with unexplained infertility and a septate uterus also have reasonable supporting evidence, particularly from controlled studies and a meta-analysis showing improved live birth rates after resection.

Where the picture gets murkier is for women who have a septate uterus found incidentally on imaging but have no history of reproductive difficulty. Here, the TRUST trial’s finding of no benefit carries the most weight, and many guidelines now suggest that routine resection in asymptomatic women is not justified. The procedure is safe, but “safe” and “beneficial” are different questions. Any surgery that does not improve outcomes for a given patient is, by definition, unnecessary for that patient, regardless of how well-tolerated it is.

If you are weighing this decision, the conversation with your surgeon should include which classification system was used to define your septum, whether your reproductive history suggests the septum is actually causing problems, which surgical technique the surgeon prefers and why, and what adhesion-prevention strategy will be used. Those details shape the risk-benefit calculation more than the broad question of whether septoplasty “works” in general.